| ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
| ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
| AGFG2 |
O95081
|
ArfGAP with FG repeats 2
|
|
2.5E-04 |
0.700 |
0.423 |
| ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
| ARHGAP24 |
Q8N264
|
Rho GTPase activating protein 24
|
|
3.9E-10 |
0.456 |
0.808 |
| ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
| CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
| CD6 |
P30203
|
CD6 molecule
|
Enzyme
|
9.3E-05 |
0.489 |
0.808 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
| CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |
| CSF1R |
P07333
|
colony stimulating factor 1 receptor
|
Kinase
|
0.13 |
0.448 |
0.808 |
| CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| CTNNA1 |
P35221
|
catenin alpha 1
|
Cellular structure
|
0.97 |
0.584 |
0.538 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| DICER1 |
Q9UPY3
|
dicer 1, ribonuclease III
|
Enzyme
|
1.00 |
0.446 |
0.846 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |